Bvf Inc Mirum Pharmaceuticals, Inc. Transaction History
Bvf Inc
- $3.15 Billion
- Q3 2024
A detailed history of Bvf Inc transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Bvf Inc holds 3,075,907 shares of MIRM stock, worth $155 Million. This represents 3.81% of its overall portfolio holdings.
Number of Shares
3,075,907
Previous 4,370,024
29.61%
Holding current value
$155 Million
Previous $149 Million
19.71%
% of portfolio
3.81%
Previous 4.57%
Shares
4 transactions
Others Institutions Holding MIRM
# of Institutions
197Shares Held
54.3MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$332 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$226 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$174 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$163 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$122 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.85B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...